KATELYN BEGEMAN: Open Payments
NPI 1215533625 · SIOUX FALLS, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$264 in 15 payments from 9 companies in 2025. Trend: 2023 $184 · 2024 $284 · 2025 $264
Food & beverage: $264
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 4 | $86 |
| Novo Nordisk Inc | 3 | $52 |
| Lilly USA, LLC | 2 | $32 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Dexcom, Inc. | 1 | $17 |
| American Regent | 1 | $15 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
| Merck Sharp & Dohme LLC | 1 | $14 |
| AstraZeneca Pharmaceuticals LP | 1 | $14 |
Products named: UBRELVY, Wegovy, MOUNJARO, INSPIRE, Dexcom G6 Transmitter, QULIPTA, INJECTAFER, CAPLYTA.
Industry payments across SD — which companies pay providers there.
